The Food and Drug Administration (FDA) has approved Restasis for treating chronic dry eye in adults and children ages 16 years and older. It’s available in single-use vials and a multiuse bottle.
The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine ophthalmic emulsion 0.05%, which ...
Restasis side effects Restasis can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Restasis. These lists do not include all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback